Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat

Neuroscience

Volumn 91, Issue 4, 1999, Pages 1461-1470

  Lopez E ^a   Pozas, E ^a   Rivera, R ^a   Ferrer, I ^a  

^a Hospitalet   (Spain)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl x; Kainic acid; Necrosis

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; RNA ANALYSIS;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAINIC ACID; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0344915157     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00704-0     Document Type: Article

References (64)

1. Allsopp T.E., Kiselev S., Wyatt S., Davies A.M. Role of bcl-2 in the brain-derived neurotrophic factor survival response. Eur. J. Neurosci. 7:1995;1266-1272.
2. Allsopp T.E., Wyatts S., Paterson H.F., Davies A.M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295-307.
3. Alonso G., Guillemain I., Dumoulin A., Privat A., Patey G. Immunolocalization of Bcl-xL/S in the central nervous system of neonatal and adult rats. Cell Tiss. Res. 288:1997;59-68.
4. Baran H., Hortnagl H. Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine. Brain Res. 495:1989;253-260.
5. Ben-Ari Y., Tremblay E., Ottersen O.P., Meldrum B.S. The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res. 191:1980;79-87.
6. Boise L.H., González-García M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Núñez G., Thompson C.B. Bcl-x: a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
7. Castrén E., Ohga Y., Berzaghi M.P., Tzimagiorgis G., Thoenen H., Lindholm D. Bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neuroscience. 61:1994;165-167.
8. Chen J., Graham S.H., Chan P.H., Lan J., Zho R.L., Simon R.P. bcl-2 is expressed in neurons that survive focal ischemia in the rat. NeuroReport. 6:1995;394-398.
9. Chen J., Graham S.H., Nakayama M., Zhu R.L., Jin K., Stetler R.A., Simon R.P. Apoptosis repressor genes Bcl-2 and Bcl-xL are expressed in the rat brain following global ischemia. J. cerebr. Blood Flow Metab. 17:1997;2-10.
10. Chen J., Zhu R.L., Nakayama M., Kawaguchi K., Jin K., Stetler R.A., Simon R.P., Graham S.H. Expression of the apoptosis-effector gene bax is up-regulated in vulnerable hippocampal neurons following global ischemia. J. Neurochem. 67:1996;64-71.
11. Choczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
12. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
13. Collins R.C., McLean M., Olney J. Cerebral metabolic response to systemic kainic acid: 14-C-deoxyglucose studies. Life Sci. 27:1980;855-862.
14. Davies J.C. The Bcl-2 family of proteins, and the regulation of cell survival. Trends Neurosci. 18:1995;355-358.
15. Deckwerth T.L., Elliott J.L., Knudson C.M., Johnson E.M. Jr., Snider W.D., Korsmeyer S.J. Bax is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:1996;401-411.
16. Dingledine R., McBain C.J., McNamara O. Excitatory amino acid receptors in epiplepsy. Trends pharmac. Sci. 11:1990;334-338.
17. Ferrer I., López E., Blanco R., Rivera R., Ballabriga J., Pozas E., Martí E. Bcl-2, Bax and Bcl-x expression in the CA1 area of the hippocampus following transient forebrain ischemia in the adult gerbil. Expl Brain Res. 121:1998;167-173.
18. Ferrer I., Martín F., Serrano T., Reiriz J., Pérez-Navarro E., Alberch J., Macaya A., Planas A.M. Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins. Acta neuropath. 90:1995;504-510.
19. Ferrer I., Pozas E., López E., Ballabriga J. Bcl-2, Bax and Bcl-x expression following ischemia in the infant rat brain. Acta neuropath. 94:1997;583-589.
20. Ferrer I., Tortosa A., Condom E., Blanco R., Macaya A., Planas A.M. Increased expression of bcl-2 immunoreactivity in the developing cerebral cortex of the rat. Neurosci. Lett. 179:1994;13-16.
21. Filipkowski R., Hetman M., Kaminska B., Kaczmare K.L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport. 5:1994;1538-1540.
22. Frankowski H., Missotten M., Fernández P.A., Martinou I., Michel P., Sadoul R., Martinou J.C. Function and expression of bcl-x gene in the developing and adult nervous system. NeuroReport. 6:1995;1917-1921.
23. García I., Martinou I., Tsujimoto Y., Martinou J.C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-304.
24. Gass P., Herdegen T., Bravo R., Miessling M. Spatiotemporal induction of immediate early genes in the rat brain after limbic seizures: effects of NMDA receptor antagonist MK-801. Eur. J. Neurosci. 5:1993;933-943.
25. González-García M., García I., Ding L., O'Shea S., Boise L.H., Thompson C.B., Núñez G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. natn. Acad. Sci. U.S.A. 92:1995;4304-4308.
26. Greenlund L. J. S., Korsmeyer S. J. and Johnson E. M. Jr. (1995) Role of bcl-2 in the survival and function of developing and mature sympathetic neurons. Neuron 15, 649-41.
27. Guarnieri T., Virgili M., Villaui L., Facchienetti F., Coutestabile A., Migani P. Pharmacological manipulation of the NMDA receptor differentially protects from systemic kainic acid neuropathology: evaluation through ornithine decarboxylase induction, morphology and GFAP immunohistochemistry. Restor. Neur. Neurosci. 5:1993;327-335.
28. Guillardon F., Wichert H., Zimmermann M. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci. Lett. 192:1995;85-88.
29. Hara A., Iwai T., Niwa M., Vematsu T., Yoshimi N., Tanaka T., Mori H. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 711:1996;249-253.
30. Hockenberry D., Nuñez G., Milliam C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
31. Hsu Y., Wolter K. G., Youle R. J. (1997) Cytosol-to-membrane redistribution of Bax and Bcl-xL during apoptosis. Proc. natn. Acad. Sci. U.S.A. 94, 3688-72.
32. Isenmann S., Stoll G., Schroeter M., Krajewski S., Reed J.C., Bahr M. Differential regulation of Bax, Bcl-2, and Bcl-x proteins in focal cortical ischemia in the rat. Brain Path. 8:1998;49-62.
33. Korsmeyer S.J. Bcl-2 initiates a new category of oncogene regulators of cell death. Blood. 80:1992;879-886.
34. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.G., Reed J.C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Path. 145:1994;1323-1336.
35. Krajewski S., Krajewska M., Shabaik A., Wang H.G., Irie S., Fong L., Reed J.C. Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res. 54:1994;5501-5507.
36. Lothman E.W., Collins R.C. Kainic acid-induced limbic motor seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
37. Mah S.P., Zhong L.T., Lin Y., Roghani A., Edwards R.H., Bredesen D.E. The proto-oncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1993;1183-1186.
38. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodríguez I., Frankowski H., Missoten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
39. Merry D.E., Veis D.J., Hickey W.F., Korsmeyer S.J. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development. 130:1994;301-311.
40. Merry D.E., Korsmeyer S.J. Bcl-2 gene family in the nervous system. A. Rev. Neurosci. 20:1997;245-267.
41. Michaelidis T.M., Sendtner M., Cooper J.D., Airaksinen M.S., Hotmann B. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron. 17:1996;75-89.
42. Minn A.J., Boise L.H., Thompson C.B. Bcl-x(s) antagonizes the protective effects of Bcl-x(l). J. biol. Chem. 271:1996;6306-6312.
43. Montpied P., Weller M., Paul S.M. N-methyl-D-aspartate receptor agonists decrease proto-oncogene bcl-2 mRNA expression in cultured rat cerebellum granule neurons. Biochem. biophys. Res. Commun. 195:1993;623-629.
44. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K.I., Nakayama K., Negishi I., Senju S., Zhang O., Fujii S., Loh D.Y. Massive cell death of immature haematopoietic cells and neurons in bcl-x-deficient mice. Science. 267:1995;1506-1509.
45. Nakayama K., Nakayama K.I., Negishi I., Kuida K., Sawa H., Loh D.Y. Targeted disruption of bcl-2ab in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. natn. Acad. Sci. U.S.A. 91:1994;3700-3704.
46. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
47. Pollard H., Charriant-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptosis cell death in hippocampal neurons. Neuroscience. 6:1994;7-18.
48. Portera-Cailliau C., Hedreen J., Rice D., Koliatos V. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
49. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
50. Roth K.A., Motoyama N., Loh D. Apoptosis of bcl-x deficient telencephalic cells in vitro. J. Neurosci. 16:1996;1753-1758.
51. Sacaan A.I., Shoepp D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139:1992;77-82.
52. Sato T., Hamada M., Bodrug S., Irie S., Iwana N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.G., Reed J.C. Interactions among the members of the bcl-2 family with a yeast two-hybrid system. Proc. natl. Acad. Sci. U.S.A. 91:1994;9238-9242.
53. Schwob J.E., Fuller T., Rice J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injection of kainic acid: a histological study. Neuroscience. 5:1980;991-1014.
54. Sedlack T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerisations with Bax. Proc. natn. Acad. Sci. U.S.A. 92:1995;7834-7838.
55. Sperck G., Lassman H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid-induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
56. Sperck G., Lassman H., Baran H., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res. 338:1985;289-295.
57. Sun A.Y., Cheng Y., Bu Q., Oldfield F. The biochemical mechanisms of the excitotoxicity of kainic acid. Molec. chem. Neuropath. 17:1992;51-63.
58. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
59. Vekrellis K., McCarthy M.J., Watson A., Whitfield J., Rubin L.L., Ham J. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development. 124:1997;1239-1249.
60. Watkins J.C., Evans R.H. Excitatory amino acids transmitters. A. Rev. Pharmac. Toxic. 21:1981;165-204.
61. Werner P., Voigt M., Kainänen K., Wisden W., Seeburg H. Cloning of a putative high affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature. 351:1991;742-744.
62. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature. 369:1994;321-323.
63. Zha H., Aima-Sempe C., Sato T., Reed J.C. Proapoptotic protein Bax heterodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. biol. Chem. 271:1996;7440-7444.
64. Zhong L.T., Hane D.J., Bredesen D.E. Bcl-2 blocks glutamate toxicity in neural cell lines. Molec. Brain Res. 19:1993;353-355.